Zymeworks Inc. - Common Stock (ZYME)

Zymeworks Inc is a biotechnology company that focuses on the development of innovative therapeutics for the treatment of cancer and other serious diseases

The company specializes in creating next-generation protein therapeutics using its proprietary platform, which allows for the design and engineering of multifunctional antibodies and other biologics. By harnessing advanced technologies, Zymeworks aims to address unmet medical needs and improve patient outcomes through its pipeline of drug candidates, which are in various stages of clinical development. The company's commitment to scientific excellence and collaboration drives its efforts to bring transformative treatments to market.